S144: IMMUNE RESTORATION AND SYNERGISTIC ACTIVITY WITH FIRST-LINE (1L) IBRUTINIB (IBR) PLUS VENETOCLAX (VEN): TRANSLATIONAL ANALYSES OF CAPTIVATE PATIENTS WITH CLL - I. Solman; R. Singh Mali; L. Scarfo; M. Choi; C. Moreno; A. Grigg; J. P. Dean; E. Szafer-Glusman (HemaSphere, 2022)